TW200635612A - Use of cyanine dyes for the diagnosis of proliferative diseases - Google Patents

Use of cyanine dyes for the diagnosis of proliferative diseases

Info

Publication number
TW200635612A
TW200635612A TW095100548A TW95100548A TW200635612A TW 200635612 A TW200635612 A TW 200635612A TW 095100548 A TW095100548 A TW 095100548A TW 95100548 A TW95100548 A TW 95100548A TW 200635612 A TW200635612 A TW 200635612A
Authority
TW
Taiwan
Prior art keywords
diagnosis
proliferative diseases
cyanine dyes
administration
less
Prior art date
Application number
TW095100548A
Other languages
English (en)
Chinese (zh)
Inventor
Kai Licha
Michael Schirner
Martin Pessel
Malte Bahner
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34933224&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW200635612(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Ag filed Critical Schering Ag
Publication of TW200635612A publication Critical patent/TW200635612A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A61K49/0034—Indocyanine green, i.e. ICG, cardiogreen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0058—Antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
TW095100548A 2005-01-07 2006-01-06 Use of cyanine dyes for the diagnosis of proliferative diseases TW200635612A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05000276A EP1679082A1 (fr) 2005-01-07 2005-01-07 Utilisation de colorants de type cyanine pour le diagnostic de maladies proliférantes

Publications (1)

Publication Number Publication Date
TW200635612A true TW200635612A (en) 2006-10-16

Family

ID=34933224

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095100548A TW200635612A (en) 2005-01-07 2006-01-06 Use of cyanine dyes for the diagnosis of proliferative diseases

Country Status (23)

Country Link
EP (2) EP1679082A1 (fr)
JP (1) JP5578765B2 (fr)
KR (1) KR20070092270A (fr)
CN (1) CN101128218A (fr)
AR (1) AR052190A1 (fr)
AU (1) AU2006204496A1 (fr)
BR (1) BRPI0606411A2 (fr)
CA (1) CA2594390C (fr)
CR (1) CR9232A (fr)
DO (1) DOP2006000005A (fr)
GT (1) GT200600001A (fr)
IL (1) IL182499A0 (fr)
MX (1) MX2007008300A (fr)
NO (1) NO20074036L (fr)
NZ (1) NZ554917A (fr)
PA (1) PA8659101A1 (fr)
PE (2) PE20060872A1 (fr)
RU (1) RU2007129919A (fr)
TW (1) TW200635612A (fr)
UA (1) UA89976C2 (fr)
UY (1) UY29323A1 (fr)
WO (1) WO2006072580A1 (fr)
ZA (1) ZA200706533B (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE374367T1 (de) * 2004-07-22 2007-10-15 Bayer Schering Pharma Ag Verwendung von cyanin-farbstoffen zur diagnose von krankheiten, welche mit angiogenese assoziert sind
EP1679082A1 (fr) * 2005-01-07 2006-07-12 Schering AG Utilisation de colorants de type cyanine pour le diagnostic de maladies proliférantes
EP1743658A1 (fr) * 2005-07-14 2007-01-17 Schering Aktiengesellschaft Imagerie optique de l'arhtrite rhumatoïde
WO2008119493A1 (fr) * 2007-03-30 2008-10-09 F. Hoffmann-La Roche Ag Composition d'anticorps monoclonaux marqués et non-marqués
US20110262354A1 (en) 2007-07-13 2011-10-27 Emory University Cyanine-containing compounds for cancer imaging and treatment
GB0803477D0 (en) 2008-02-26 2008-04-02 Ge Healthcare As Therapy selection method
CN102099059B (zh) * 2008-06-13 2015-09-23 西塞医疗中心 用于癌症靶向治疗的小分子配体-药物轭合物
GB0814960D0 (en) * 2008-08-15 2008-09-24 Ge Healthcare As Method for detecting dysplasia
JP2012532846A (ja) 2009-07-09 2012-12-20 エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト インビボ腫瘍脈管構造画像処理
CA2768330A1 (fr) 2009-07-28 2011-02-03 F. Hoffmann-La Roche Ag Procede non invasif d'imagerie optique in vivo
AU2010286592B2 (en) 2009-08-28 2015-08-13 Visen Medical, Inc. Systems and methods for tomographic imaging in diffuse media using a hybrid inversion technique
JP2011046663A (ja) 2009-08-28 2011-03-10 Fujifilm Corp 近赤外蛍光造影剤
JP2011046662A (ja) 2009-08-28 2011-03-10 Fujifilm Corp 近赤外蛍光造影剤
US8401619B2 (en) 2009-09-22 2013-03-19 Visen Medical, Inc. Systems and methods for virtual index-matching of diffusive media
WO2011138462A1 (fr) 2010-05-07 2011-11-10 F. Hoffmann-La Roche Ag Procédé de diagnostic pour la détection de cellules ex vivo
WO2012119999A1 (fr) 2011-03-07 2012-09-13 F. Hoffmann-La Roche Ag Moyens et procédés destinés aux tests in vivo d'anticorps thérapeutiques
EP2683413A1 (fr) 2011-03-07 2014-01-15 F.Hoffmann-La Roche Ag Sélection in vivo d'anticorps actifs thérapeutiquement
KR101373108B1 (ko) 2012-01-20 2014-03-27 이화여자대학교 산학협력단 폴리메틴 체인에 메조-반응작용기를 갖는 신규한 시아닌 유도체 및 이의 제조방법
CN102608051B (zh) * 2012-02-21 2015-04-08 中国科学院化学研究所 用于诊断白血病的试剂盒
CN102703569B (zh) * 2012-05-24 2014-04-09 中国科学院化学研究所 菁染料的新用途
CN102706787B (zh) * 2012-05-24 2015-04-08 中国科学院化学研究所 菁染料的新用途
CN104853669B (zh) 2012-10-15 2017-07-21 文森医学公司 具有荧光及生物发光源的交叉形态加权特征的漫射介质成像的系统、方法及设备
US20150182518A1 (en) * 2012-10-26 2015-07-02 Canon Kabushiki Kaisha Cancer cell inhibitory drug and cancer stem-cell detection probe
WO2014092958A1 (fr) * 2012-12-10 2014-06-19 Molecular Targeting Technologies, Inc. Compositions et procédés de diagnostic de maladies oculaires
JP6681334B2 (ja) 2013-12-31 2020-04-15 メモリアル スローン ケタリング キャンサー センター リアルタイムの蛍光源のマルチチャネル撮像のためのシステム、方法、および装置
RU2565645C1 (ru) * 2014-09-05 2015-10-20 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации Способ рентгендиагностики глубины инвазии рецидива рака вульвы в мягкие ткани
EP3233134B1 (fr) 2014-12-15 2020-03-25 Memorial Sloan-Kettering Cancer Center Peptides cycliques ayant une sélectivité améliorée de liaison aux nerfs, nanoparticules liées auxdits peptides cycliques, et utilisation de ceux-ci pour l'imagerie in vivo en temps réel des tissus nerveux
CA3007657A1 (fr) 2015-12-15 2017-06-22 Memorial Sloan Kettering Cancer Center Systemes et procedes d'imagerie pour differenciation tissulaire, par exemple pour visualisation peroperatoire
US11660354B2 (en) 2016-11-30 2023-05-30 Memorial Sloan Kettering Cancer Center Inhibitor-functionalized ultrasmall nanoparticles and methods thereof
CN111970960A (zh) 2018-03-30 2020-11-20 珀金埃尔默健康科学有限公司 使用短波红外(swir)投影层析成像对解剖器官和内含物进行3d重建的系统和方法
EP4015004A1 (fr) 2020-12-18 2022-06-22 Phi Pharma SA Peptides ramifiés spécifiques de protéoglycane

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000095758A (ja) * 1998-09-18 2000-04-04 Schering Ag 近赤外蛍光造影剤および蛍光造影方法
DE19917713A1 (de) * 1999-04-09 2000-10-19 Diagnostikforschung Inst Kurzkettige Peptid-Farbstoffkonjugate als Konstrastmittel für die optische Diagnostik
DE19947559A1 (de) * 1999-09-24 2001-04-19 Schering Ag Antikörper-Farbstoffkonjugate gegen Zielstrukturen der Angiogenese zur intraoperativen Tumorranddarstellung
MXPA05007668A (es) * 2003-01-24 2005-09-30 Schering Ag Colorantes hidrofilicos de cianina, reactivos a tiol y conjugados de los mismos con biomoleculas para diagnostico por fluorescencia.
ATE374367T1 (de) * 2004-07-22 2007-10-15 Bayer Schering Pharma Ag Verwendung von cyanin-farbstoffen zur diagnose von krankheiten, welche mit angiogenese assoziert sind
EP1679082A1 (fr) * 2005-01-07 2006-07-12 Schering AG Utilisation de colorants de type cyanine pour le diagnostic de maladies proliférantes

Also Published As

Publication number Publication date
NZ554917A (en) 2010-01-29
CR9232A (es) 2007-11-23
JP5578765B2 (ja) 2014-08-27
AU2006204496A1 (en) 2006-07-13
CA2594390A1 (fr) 2006-07-13
DOP2006000005A (es) 2006-07-15
PE20100449A1 (es) 2010-07-25
KR20070092270A (ko) 2007-09-12
UY29323A1 (es) 2006-10-02
NO20074036L (no) 2007-08-03
CA2594390C (fr) 2013-10-22
EP1679082A1 (fr) 2006-07-12
EP1833513B1 (fr) 2013-03-06
ZA200706533B (en) 2009-07-29
JP2008526802A (ja) 2008-07-24
MX2007008300A (es) 2007-09-07
AR052190A1 (es) 2007-03-07
RU2007129919A (ru) 2009-02-20
EP1833513A1 (fr) 2007-09-19
WO2006072580A1 (fr) 2006-07-13
BRPI0606411A2 (pt) 2009-06-23
PA8659101A1 (es) 2006-09-08
IL182499A0 (en) 2007-09-20
CN101128218A (zh) 2008-02-20
PE20060872A1 (es) 2006-10-01
UA89976C2 (ru) 2010-03-25
GT200600001A (es) 2006-08-22

Similar Documents

Publication Publication Date Title
TW200635612A (en) Use of cyanine dyes for the diagnosis of proliferative diseases
TW200700406A (en) Novel thiophene derivatives
TW200716552A (en) Novel thiophene derivatives
MY147949A (en) Hydrogenated benzo[c]thiophene derivatives as immunomodulators
TW200727920A (en) New regimens for oral monophasic contraceptives
MY154909A (en) Novel thiophene derivatives
DE602005026789D1 (de) Le
MX2010005889A (es) Derivados de tiofeno como agonistas de s1p1/edg1.
PL2026803T3 (pl) Kompozycje R(+) i S(-) pramipeksolu i sposoby ich zastosowania
TW200626132A (en) Topical nepafenac formulations
TW200731987A (en) Cytotoxicity mediation of cells evidencing surface expression of CD44
IL191763A0 (en) Pyrrolo [2,3-b]pyridine derivatives as h3 receptor modulators
HK1175846A1 (en) Cytotoxicity mediation of cells evidencing surface expression of cd44 cd44
EP2004637A1 (fr) Azines à noyau condensées et substituées et leur utilisation pour une thérapie anti-cancéreuse
WO2011053901A3 (fr) Nanostructures magnetiques utilisees en tant qu'agents theranostiques
IL191751A0 (en) Pyrrolo[2,3-c]pyridine derivatives
SI1727817T1 (sl) Azabiciklooktan-3-onski derivati in njihova uporaba
GB2449044A (en) Cytotoxicity mediation of cells evidencing surface expression of cd63
TW200637875A (en) Cytotoxicity mediation of cells evidencing surface expression of CD63
PT2185561E (pt) Derivados de 1,2,3,4-tetra-hidropirrolo(1,2-a)pirazina-6- carboxamidas e de 2,3,4,5-tetra-hidropirrolo(1,2-a)-diazepina-7- carboxamidas, sua preparação e sua aplicação em terapia
TNSN05226A1 (en) Treatment of proliferative diseases with epothilone derivatives and radiation
MY139010A (en) 6-azo-5, 5'-dihydroxy -7,7'-disulfo-2-2'-dinaphthylamine derivatives
TW200610526A (en) Novel hydrophilic analogs of 4,8-dihydrobenzodithiophene-4,8-diones as anticancer agents
WO2007121883A3 (fr) Dérivés de 1,4:3,6-dianhydromannitol et leur utilisation
TW200744645A (en) Contrast agents for myocardium perfusion imaging